Effects of Innovative Aerobic Exercise Training in Cystic Fibrosis
Purpose
This study will be a randomized controlled trial in patients with cystic fibrosis and conducted over a consecutive twelve-week period. A comparison standard of care group will be used as a control to an interventional exercise group. The study evaluates the effectiveness of standard of care therapy + exercise compared to standard of care only for improving cardiorespiratory-fitness in CF patients.
Condition
- Cystic Fibrosis
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- diagnosed with Cystic Fibrosis - Prescribed and taking for 28 days ivacaftor-tezacaftor-elexacaftor (Trikafta) - 18 years and older
Exclusion Criteria
- 17 years of age or less - not eligible for ivacaftor-tezacaftor-elexacaftor (Trikafta) - inability to exercise - pregnancy - status post lung transplantation - already participating in more than 150 minutes of aerobic exercise per week
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel Assignment
- Primary Purpose
- Treatment
- Masking
- None (Open Label)
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Active Comparator exercise |
exercise prescription + standard of care |
|
|
No Intervention no exercise |
no exercise prescription + standard of care |
|
Recruiting Locations
University of Kansas Medical Center
Kansas City, Kansas 66160
Kansas City, Kansas 66160
More Details
- Status
- Unknown status
- Sponsor
- University of Kansas Medical Center